1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Resectable Sarcoma: new trials by email Literature Review of Resectable Sarcoma trials Research Report on Resectable Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO) Doxorubicin, Ifosfamide, INCMGA00012 - Resectable Sarcoma | Phase 2 | Active not recruiting | Institut Bergonié | 66 | 2022-12-07 | 2026-10-08 |
Sarcoma (1)
Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Connective and Soft Tissue (1)
Doxorubicin (1) · Ifosfamide (1)
France (1)
2023 (1)